Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Probiotic BB-12 May Reduce Respiratory Illness in Infants - Nutraceuticals World

What are you searching for?

Sign in
Research

Probiotic BB-12 May Reduce Respiratory Illness in Infants

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Daily supplementation with Chr. Hansen’s probiotic strain BB-12 may significantly reduce the occurrence of respiratory infections in early childhood, according to a federally funded, clinical study published in the September issue of British Journal of Nutrition.

 
In this double-blind, placebo-controlled study, 109 newborn infants were assigned randomly to a probiotic group receiving BB-12 or to a control group receiving placebo. BB-12 was administered to the healthy breastfed infants twice a day from the age of 1-2 months to 8 months with a pacifier or a spoon.
 
The main finding was that BB-12 reduced respiratory infections, as 65% of children in the BB-12 group and 94% in the control group had experienced one or more episodes of respiratory infections at the 8-month examination. For further information: www.chr-hansen.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters